A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 123
[Display Entries]
100 entries :
      (Publication year, Descending)
100 entries :
      (Publication year, Ascending)
all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : DAB
Long Form : p-dimethylaminoazobenzene
No. Year Title Co-occurring Abbreviation
2016 Molecular aspects and chemoprevention of dimethylaminoazobenzene-induced hepatocarcinogenesis: A review. ROS
2015 Evaluation of the repeated-dose liver micronucleus assay with p-dimethylaminoazobenzene. ---
2010 Effect of antioxidant vitamins A, C, E and their analogues on azo-dye binding protein in liver of rats treated with p-dimethylaminoazobenzene. ---
2010 Intrinsic apoptosis and NF-kappaB signaling are potential molecular targets for chemoprevention by black tea polyphenols in HepG2 cells in vitro and in a rat hepatocarcinogenesis model in vivo. ---
2009 Black tea polyphenols target matrix metalloproteinases, RECK, proangiogenic molecules and histone deacetylase in a rat hepatocarcinogenesis model. HCC
2009 Evaluation of a liver micronucleus assay with 12 chemicals using young rats (II): a study by the Collaborative Study Group for the Micronucleus Test/Japanese Environmental Mutagen Society-Mammalian Mutagenicity Study Group. 2,4-DAT, 2,4-DNT, 2-AAF, DEN, DMN, MMC, MN
2007 Dietary supplementation of vitamin A, C and E prevents p-dimethylaminoazobenzene induced hepatic DNA damage in rats. ---
2006 Genotoxicity studies OF p-dimethylaminoazobenzene (DAB). ---
2006 Homeostatic response under carcinogen withdrawal, heme oxygenase 1 expression and cell cycle association. HC, HO-1, HR
10  2006 Photoisomerization of azobenzenes and spirocompounds in nematic and in twisted nematic liquid crystals. NDAB, NDAB, SO, SP
11  2005 Evaluation of liver and peripheral blood micronucleus assays with 9 chemicals using young rats. A study by the Collaborative Study Group for the Micronucleus Test (CSGMT)/Japanese Environmental Mutagen Society (JEMS)-Mammalian Mutagenicity Study Group (MMS). CPDA, CSGMT, DEHP, DMN, JEMS, MDA, MMS, MMS
12  2004 Cell cycle arrest and modulation of HO-1 expression induced by acetyl salicylic acid in hepatocarcinogenesis. ASA, HO-1
13  2004 Distribution of oval cells and c-myc mRNA expression in mouse hepatocarcinogenesis. HCC
14  2003 [Tumor-associated hetero-organic antigens as markers of deranged cell differentiation and malignancy]. DENA
15  2001 On the promoting action of tamoxifen in a model of hepatocarcinogenesis induced by p-dimethylaminoazobenzene in CF1 mice. TMX
16  2001 Oxidative DNA damage induced by an N-hydroxy metabolite of carcinogenic 4-dimethylaminoazobenzene. 8-oxodG, N-OH-AAB
17  1999 Drug metabolizing enzyme system and heme pathway in hepatocarcinogenesis. AIA, ALA-S, MHO
18  1998 beta-Carotene partially prevents the damage induced by 1,4-dimethylaminoazobenzene in mice. HC
19  1998 Hepatic enzymatic metabolism alterations and oxidative stress during the onset of carcinogenesis: protective role of alpha-tocopherol. ---
20  1997 Altered heme pathway regulation and drug metabolizing enzyme system in a mouse model of hepatocarcinogenesis: effect of veronal. ---
21  1997 Detection of chemically induced DNA lesions in multiple mouse organs (liver, lung, spleen, kidney, and bone marrow) using the alkaline single cell gel electrophoresis (Comet) assay. ENU, SCG
22  1997 Mitochondrial and cytosolic rhodanese from liver of DAB-treated mice. III. Inhibition kinetic studies. ---
23  1995 Isolation and partial purification of mitochondrial and cytosolic rhodanese from liver of normal and p-dimethylaminoazobenzene treated mice. ---
24  1995 Mitochondrial and cytosolic rhodanese from liver of DAB treated mice. II. Some properties and spectral studies. ---
25  1995 [A comparative study of the synthesis of membrane hetero-organic antigens of kidney origin on tissue slices and isolated cells after a single carcinogenic exposure in rats]. DENA
26  1993 [Effects of platelet aggregating inhibitor on pulmonary metastases of tumor cells after surgical resection]. ---
27  1992 Azoreductase activity by purified rabbit liver aldehyde oxidase. NMN
28  1992 Formation and 32P-postlabeling of DNA and tRNA adducts derived from peroxidative activation of carcinogenic azo dye N,N-dimethyl-4-aminoazobenzene. ---
29  1992 Heme biosynthesis pathway regulation in a model of hepatocarcinogenesis pre-initiation. ALA-S, MHO
30  1992 Multiple mechanisms in hepatic microsomal azoreduction. ---
31  1991 [The effect of immunological response on wound healing in rat with liver cirrhosis]. DNFB
32  1990 Azoreduction of dimethylaminoazobenzene (DAB) in primary cultures of rat hepatocytes. Effect of hypolipidemic agents. ---
33  1990 Characteristics of two classes of azo dye reductase activity associated with rat liver microsomal cytochrome P450. ---
34  1990 Microsomal reduction of dimethylaminoazobenzene (DAB). Selective effects of carbon dioxide asphyxiation versus decapitation of animals and variation with age, sex and species. ---
35  1990 Transgenic mice containing hepatitis B virus sequences are more susceptible to carcinogen-induced hepatocarcinogenesis. HBsAg, HBV
36  1989 Immunoassay employing surface-enhanced Raman spectroscopy. HABA, SERRS, SERS, TSH
37  1989 Interaction between cholinergic neurons and substance P or calcitonin gene-related peptide terminals of the rat sacral intermediolateral nucleus: double immunostaining at the light and electron microscopic levels. CAT, CGRP, CGRP-I, PAP, SP, SP-I
38  1989 [Ultrastructural changes in the hepatocytes in rats with dimethylaminoazobenzene poisoning]. ---
39  1988 Activation of a ribosomal protein S6 kinase during the 4-dimethylaminoazobenzene-induced rat hepatocarcinogenesis. ---
40  1988 Mechanism of azoreduction of dimethylaminoazobenzene by rat liver NADPH-cytochrome P-450 reductase and partially purified cytochrome P-450. Oxygen and carbon monoxide sensitivity and stimulation by FAD and FMN. ---
41  1988 Modulating influence of dehydroepiandrosterone administration on the morphology and enzyme phenotype of dimethylaminoazobenzene-induced hepatocellular foci and nodules. AP, CAT, DHEA, G6Pase, GST-P, PHO
42  1987 Localized hepatocarcinogenesis: the response of the liver and kidney to implanted carcinogens. 3-MC, ANIT, ANT, Chol, HCC, MFH
43  1987 Microsomal azoreduction and glucuronidation in the metabolism of dimethylaminoazobenzene by the rat liver. DEN, UDPGT
44  1986 Azoreduction of N,N-dimethyl-4-aminoazobenzene (DAB) by rat hepatic microsomes. Selective induction by clofibrate. ---
45  1986 Clofibrate selectively induces azoreduction of dimethylaminoazobenzene (DAB) by rat liver microsomes. ---
46  1986 Combined radiotherapy, chemotherapy, and maltose tetrapalmitate immunotherapy in the treatment of 4'dimethylaminoazobenzene-induced liver cancer. CY, MTP
47  1986 Effect of phenobarbital and beta-naphthoflavone on oxidative metabolism of N,N-dimethyl-4-aminoazobenzene by regenerating rat-liver microsomes and its response to sulphydryl compounds. BNF, MAB, PB
48  1986 Regulation of thiol environment of the N-demethylation and ring hydroxylation of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes. BNF, DTT, NEM, PB
49  1985 Studies on microsomal azoreduction. N,N-dimethyl-4-aminoazobenzene (DAB) and its derivatives. MAB, NEM, PHMB
50  1985 [Detection of the common features in the antigenic structure and the spectra of the phosphoprotein kinase activity proper of the water-soluble fractions of DNA-free nuclear nonhistone proteins from hepatomas and the liver in rats following a single administration of hepatocarcinogens]. NHP
51  1985 [Influence of riboflavin upon the development of dimethylaminoazobenzene (DAB) induced liver cancer in rats]. ---
52  1984 Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB). ---
53  1984 Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on metabolism of N,N-dimethyl-4-aminoazobenzene (DAB) by rat liver microsomes. BHA, BHT, PB
54  1984 Mutagenicity to Salmonella of the mono methylamino and N-cyanoethyl analogues of 4-dimethylaminoazobenzene (DAB) and 6-dimethylaminophenylazobenzthiazole (6BT). ---
55  1984 [Comparison of the effect of different carcinogens on the skin of rats]. DAAE, DMBA, MNNG, MNU
56  1984 [Functional state of the sympathetic nervous system in animals during chemical carcinogenesis]. ---
57  1984 [Glycogen distribution in rat hepatocyte populations after a single exposure to 4-dimethylaminoazobenzine and subsequent injections of phenobarbital]. ---
58  1983 Cyclic amines as less mutagenic replacements for dimethyl amino (--NMe2) substituents on aromatic organic compounds: implications for carcinogenicity and toxicity. ---
59  1983 Cytosolic factors that alter the metabolism of N,N-dimethyl-4-aminoazobenzene by rat liver microsomes. ---
60  1983 Effect of glutathione on the metabolism of N,N-dimethyl-4-aminoazobenzene by rat liver microsomes. ---
61  1983 Initiation/promotion versus complete carcinogenicity in the rodent liver. ---
62  1983 Purification of mixed-function amine oxidase from rat liver microsomes. DMA, MFAO, SDS
63  1983 The major role of glutathione in the metabolism and excretion of N,N-dimethyl-4-aminoazobenzene in the rat. 4'-sulphonyloxy-MAB, AB
64  1983 The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 5I). 4PhDAB
65  1983 Uptake and hepatobiliary fate of two hepatocarcinogens, N,N-dimethyl-4-aminoazobenzene and 3'-methyl-N,N-dimethyl-4-aminoazobenzene, in the rat. 3'-Me-DAB
66  1982 A correlation of the rate of N-hydroxylation of aminoazo dyes with their carcinogenic activity in the rat. MAB, N-OH-MAB
67  1982 Comparisons between carcinogenic potency and mutagenic potency to Salmonella in a series of derivatives of 4-dimethylaminoazobenzene (DAB). ---
68  1982 Effect of drugs and hormones on rat liver dimethylaminoazobenzene reductase activity. ---
69  1982 Effect of hepatocarcinogens on epoxide hydrolase and other xenobiotic metabolizing enzymes. AAF, DEN, DNT
70  1982 eIF-2 initiation factor activity in Yoshida ascites hepatoma AH 130 cells and in 4-dimethylaminoazobenzene-induced liver tumor tissue during growth. eIF-2
71  1982 Factors affecting the response of N,N-dimethylaminoazobenzene in the Ames microbial mutation assay. ---
72  1982 Formation of N-(glutathion-S-methylene)-4-aminoazobenzene following metabolic oxidation of the N-methyl group of the carcinogen, N-methyl-4-aminoazobenzene. AB, MAB
73  1982 Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat. BNF, MC, PB, PCN
74  1981 Polyamine concentration, activity of the ribosomal dissociation factor and proportion of ribosomes active in protein synthesis in the 4-dimethylaminoazobenzene-induced rat hepatoma. ---
75  1981 The effects of pre-incubation period and norharman on the mutagenic potency of 4-dimethylaminoazobenzene and 3'-methyl-4-dimethylaminoazobenzene in S. typhimurium. 3'-Me-DAB
76  1981 Unscheduled DNA synthesis induced by 4-aminoazobenzene, N-hydroxy-4-aminoazobenzene, and their derivatives in primary cultures of rat and mouse hepatocytes. AAB, MAB, MeO, N-OH, UDS
77  1980 DAB-induced changes in NMR relaxation times, water and iron content of rat tissue. ---
78  1980 Effect of chlorpromazine hydrochloride on carcinogen-metabolizing enzymes: liver microsomal dimethylnitrosamine demethylase, 4-dimethylaminoazobenzene reductase, and aryl hydrocarbon hydroxylase. CPZ, DMN
79  1980 Formation of 3-(glutathion-S-YL)-N-methyl-4-aminoazobenzene and inhibition of aminoazo dye-nucleic acid binding in vitro by reaction of glutathione with metabolically-generated N-methyl-4-aminoazobenzene-N-sulfate. MAB-N-sulfate, N-BzO-MAB, N-HO-MAB
80  1980 Induction and inhibition of the metabolism and biliary excretion of the azo dye carcinogen, N,N-dimethyl-4-aminoazobenzene (DAB), in the rat. 4'-OH-MAB, MC, PB
81  1980 Microinterferometric characterization of cells isolated from primary hepatomata and from allografts of hepatomata by 4-dimethylaminoazobenzene. ---
82  1979 DNA damage induced in vivo evaluated with a non-radioactive alkaline elution technique. AAF, DEN, DMN, MMS
83  1979 Glutathione adducts of N-methyl-4-aminoazobenzene formed in vivo and by reaction of N-benzoyloxy-N-methyl-4-aminoazobenzene with glutathione. N-BzO-MAB
84  1978 Biliary excretion of N,N-dimethyl-4-aminoazobenzene (DAB) in the rat. Effects of pretreatment with inducers and inhibitors of the mixed-function oxidase system and with agents that deplete liver glutathione. ---
85  1978 Effect of prostaglandins and hormones on cyclic AMP formation in rat hepatomas and liver tissue. AAF, PG
86  1978 N,N-diethyl-4-aminoazobenzene (DEAB): acute actions with respect to possible carcinogenicity as well as the role of solvents. Morphological and pharmacological investigations. DEAB, SD, WI
87  1978 [Effect of single exposure to the carcinogen 4-dimethylaminoazobenzene on several properties of rat liver mitochondria]. ---
88  1976 Cytochemical studies of rat liver glycogen and alkaline phosphatase under the effect of hepatocarcinogens. ---
89  1976 Cytological studies of the effect of hepatocarcinogens on liver cells of rats. ---
90  1975 Comparative effect of phenobarbital and 3-methyl-cholanthrene on azodye metabolism in rat liver. I. In vitro studies on detoxication and activation processes. 3-MC, PB
91  1975 Comparative effect of phenobarbital and 3-methylcholanthrene on azo dye metabolism in rat liver. II. In vivo binding of metabolites to cellular macromolecules. 3-MC, PB
92  1975 [Ribosomal apparatus of liver cells in the process of carinogenesis induced by 4-dimethylaminoazobenzene]. ---
93  1973 [Effect of various androgens on carcinogenesis of in the rat liver induced by para-dimethylaminoazobenzene (DAB)]. ---
94  1972 [Effect of the ingestion of p-dimethylaminoazobenzene (DAB) and 3' methyl-DAB on the capacities of activation of DAB and azoreduction of liver microsomes in the rat]. ---
95  1972 [Influence exerted by 2 steroid alkaloids, funtumine and irehdiamine A, on hepato-carcinogenesis induced in the rat with p-dimethylamino-azobenzene (DAB)]. ---
96  1972 [Influence exerted by various estrogens on the process of liver cancerization in male rats poisoned by para-dimethylaminoazobenzene (DAB)]. ---
97  1972 [Influence of pregnandiol and allopregnandiol on the process of liver cancerization in male rats poisoned by para dimethylaminoazobenzene (DAB)]. ---
98  1972 [Inhibition by ethionine of the carcinogenic action of dimethylamioazobenzene (DAB)]. ---
99  1971 Effect of papain on the carcinogenesis by P-dimethylaminoazobenzene (DAB). ---
100  1971 [Inhibitory actions of pregnenolone on cancerization of the liver, and favourable to the development of neoplasms of the interstitial gland of the testis, in rats poisoned by para-dimethylaminoazobenzene (DAB)]. ---